+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Obstructive Hypertrophic Cardiomyopathy (HCM) - Pipeline Insight, 2025 - Product Thumbnail Image

Obstructive Hypertrophic Cardiomyopathy (HCM) - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
PD-1 Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

PD-1 Inhibitor - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Primary Mitochondrial Myopathies - Pipeline Insight, 2025 - Product Thumbnail Image

Primary Mitochondrial Myopathies - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Pseudomonas Aeruginosa-Induced Lung Injury - Pipeline Insight, 2025 - Product Thumbnail Image

Pseudomonas Aeruginosa-Induced Lung Injury - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Punctate Epitheliopathy - Pipeline Insight, 2025 - Product Thumbnail Image

Punctate Epitheliopathy - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Carpal Tunnel Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Carpal Tunnel Syndrome - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Central Retinal Venous Occlusion - Pipeline Insight, 2025 - Product Thumbnail Image

Central Retinal Venous Occlusion - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Chemotherapy-Induced Hearing Loss - Pipeline Insight, 2025 - Product Thumbnail Image

Chemotherapy-Induced Hearing Loss - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Somatostatinoma - Pipeline Insight, 2025 - Product Thumbnail Image

Somatostatinoma - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Chronic Cutaneous Ulcers - Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Cutaneous Ulcers - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Substance Use Disorder (SUD) - Pipeline Insight, 2025 - Product Thumbnail Image

Substance Use Disorder (SUD) - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
From
Topical Skin Infection Treatment - Pipeline Insight, 2025 - Product Thumbnail Image

Topical Skin Infection Treatment - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Trichomoniasis - Pipeline Insight, 2025 - Product Thumbnail Image

Trichomoniasis - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Uterine Fibroids & Endometriosis - Pipeline Insight, 2025 - Product Thumbnail Image

Uterine Fibroids & Endometriosis - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Chronic Insomnia - Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Insomnia - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Chronic Ocular Pain - Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Ocular Pain - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Chronic Pruritus (CP) - Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Pruritus (CP) - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Chronic Refractory Gout - Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Refractory Gout - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Clear Cell Renal Cell Carcinoma (ccRCC) - Pipeline Insight, 2025 - Product Thumbnail Image

Clear Cell Renal Cell Carcinoma (ccRCC) - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more